Eric Wenzler
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 40
- Pharmacology 33
- Antibiotics Pharmacokinetics and Efficacy 32
- Co-authors
- Mark Biagi (15 shared papers)Keith A. Rodvold (11 shared papers)Larry H. Danziger (16 shared papers)David A. Butler (7 shared papers)Amanda Harrington (9 shared papers)Zackery P. Bulman (10 shared papers)Xing Tan (6 shared papers)Shitalben Patel (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (12 papers)Open Forum Infectious Diseases (9 papers)Diagnostic Microbiology and Infectious Disease (6 papers)Antibiotics (4 papers)Clinical Infectious Diseases (4 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Eric Wenzler
78 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 99
- Applied Microbiology and Biotechnology 298
- Molecular Medicine 762
- Endocrinology 239
- Pharmacology 495
- Clinical Biochemistry 173
Countries citing papers authored by Eric Wenzler
This map shows the geographic impact of Eric Wenzler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wenzler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wenzler more than expected).
Fields of papers citing papers by Eric Wenzler
This network shows the impact of papers produced by Eric Wenzler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wenzler. The network helps show where Eric Wenzler may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Wenzler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 98 | |
| 2 | 2016 | 96 | |
| 3 | 2019 | 88 | |
| 4 | 2017 | 79 | |
| 5 | 2021 | 77 | |
| 6 | 2017 | 53 | |
| 7 | 2019 | 53 | |
| 8 | 2020 | 50 | |
| 9 | 2017 | 49 | |
| 10 | 2019 | 47 | |
| 11 | 2015 | 47 | |
| 12 | 2015 | 46 | |
| 13 | 2017 | 42 | |
| 14 | 2020 | 38 | |
| 15 | 2020 | 36 | |
| 16 | 2021 | 33 | |
| 17 | 2021 | 32 | |
| 18 | 2023 | 31 | |
| 19 | 2017 | 28 | |
| 20 | 2020 | 27 |
About Eric Wenzler
Eric Wenzler is a scholar working on Molecular Medicine, Pharmacology, Epidemiology, Infectious Diseases and Clinical Biochemistry, having authored 80 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (40 papers), Antibiotics Pharmacokinetics and Efficacy (32 papers), Antibiotic Use and Resistance (14 papers), Bacterial Identification and Susceptibility Testing (14 papers), Pneumonia and Respiratory Infections (9 papers), Vibrio bacteria research studies (6 papers), Infections and bacterial resistance (5 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (298 citations), Molecular Medicine (762 citations), Endocrinology (239 citations), Pharmacology (495 citations) and Clinical Biochemistry (173 citations). Eric Wenzler has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Mark Biagi, Keith A. Rodvold, Larry H. Danziger, David A. Butler, Amanda Harrington, Zackery P. Bulman, Xing Tan, Shitalben Patel, Debra A. Goff and Dustin R. Fraidenburg. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Open Forum Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Antibiotics and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.